Nicolas Dumonteil
Overview
Explore the profile of Nicolas Dumonteil including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
144
Citations
1800
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Durand E, Eltchaninoff H, Tchetche D, Levesque T, Garmendia C, Garmendia C, et al.
J Am Coll Cardiol
. 2025 Mar;
85(9):896-907.
PMID: 40044295
Background: In a context of extending transcatheter aortic valve replacement (TAVR) to patients with a longer life expectancy, it is important to better document the incidence and outcomes of reintervention....
2.
Voll F, Olivecronab G, Ferenc M, Hellig F, Schlundt C, Wohrle J, et al.
Cardiovasc Interv Ther
. 2025 Feb;
40(2):296-305.
PMID: 39918675
New-generation single-layer polytetrafluorethylene (PTFE-) or polyurethane (PU-) covered stent (CS) for the treatment of coronary artery perforation (CAP) during PCI offer high procedural efficacy. To evaluate the comparative long-term safety...
3.
Coronary Events After Transcatheter Aortic Valve Replacement: Insights From the France TAVI Registry
Zendjebil S, Akodad M, Iung B, Dumonteil N, Cuisset T, le Breton H, et al.
JACC Cardiovasc Interv
. 2025 Jan;
18(2):229-243.
PMID: 39880575
Background: The prevalence of coronary artery disease in patients undergoing transcatheter aortic valve replacement (TAVR) is high. Treatment of a coronary events (CE) after TAVR can be technically challenging. Objectives:...
4.
Aarts H, van Nieuwkerk A, Hemelrijk K, Salgado Fernandez J, Tchetche D, de Brito Jr F, et al.
JACC Cardiovasc Interv
. 2025 Jan;
18(1):89-99.
PMID: 39814498
Background: Transcatheter aortic valve replacement (TAVR) harbors the risk of periprocedural complications that require emergent cardiac surgery, or "surgical bailout." Surgical bailout intends to be lifesaving but is associated with...
5.
Bay B, Gitto M, Sartori S, Vogel B, Tchetche D, Petronio A, et al.
Catheter Cardiovasc Interv
. 2025 Jan;
105(4):891-899.
PMID: 39776285
Background: Limited data exist on the impact of polyvascular disease (PolyVD) on clinical outcomes in female patients undergoing transcatheter aortic valve replacement (TAVR). We therefore sought to investigate clinical outcomes...
6.
Di Muro F, Vogel B, Sartori S, Tchetche D, Feng Y, Petronio A, et al.
Am J Cardiol
. 2024 Nov;
236():56-63.
PMID: 39522578
Limited evidence exists concerning the prognostic impact of baseline left ventricular ejection fraction (LVEF) on outcomes among women undergoing transcatheter aortic valve implantation (TAVI), which we aimed to investigate in...
7.
Cesario V, Oliva O, De Biase C, Beneduce A, Boiago M, Dumonteil N, et al.
J Clin Med
. 2024 Oct;
13(20).
PMID: 39458073
Over the past few years, transcatheter aortic valve implantation (TAVI) imposed itself as the first-choice therapy for symptomatic aortic stenosis (AS) in elderly patients at surgical risk. There have been...
8.
Hahn R, Makkar R, Makar M, Davidson C, Puthamana J, Zahr F, et al.
JACC Cardiovasc Interv
. 2024 Sep;
17(18):2093-2112.
PMID: 39322362
With the recent approval of the transcatheter EVOQUE tricuspid valve replacement system to treat severe, symptomatic tricuspid regurgitation, there is a need to define the appropriate patient population and anatomical...
9.
Coisne A, Ludwig S, Scotti A, Ben Ali W, Weimann J, Duncan A, et al.
JACC Cardiovasc Interv
. 2024 Sep;
17(18):2141-2153.
PMID: 39243262
Background: Patients with mitral regurgitation (MR) and morphologic presence of relevant mitral annular calcification (MAC) represent a challenging phenotypic subset with limited treatment options. Objectives: The aim of this study...
10.
van Nieuwkerk A, Aarts H, Hemelrijk K, Urbano Carrillo C, Tchetche D, de Brito Jr F, et al.
J Am Heart Assoc
. 2024 Aug;
13(17):e032901.
PMID: 39190595
Background: Cerebrovascular events remain one of the most devastating complications of transcatheter aortic valve implantation (TAVI). Data from real-world contemporary cohorts on longitudinal trends and outcomes remain limited. The aim...